Arcadia Therapeutics
Company

Arcadia Therapeutics

Pharmaceutical Manufacturing 2 employees
Employees
2
Contacts
1
Emails
1
Phones
1

Arcadia Therapeutics Overview

Industry
Pharmaceutical Manufacturing
Employees
2
Founded
2023
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
Keywords

About Arcadia Therapeutics

ASD (autism spectrum disorder) has now reached an alarming prevalence of 1 in 36, marking a significant 22% surge in reported prevalence rates by the CDC since 2021. At Arcadia Therapeutics (AT), we are committed to advancing understanding, supporting innovative research, and providing vital therapeutics for those living with ASD. We believe that current treatments with OT, PT, Speech, ABA, and feeding therapy are merely a band-aid that do not ultimately alter the ASD process at a cellular level. At Arcadia, we look forward to using novel therapies to see if we can alter ASD at a cellular level with new treatments that can help children that traditional medicine has left with no options.

Arcadia Therapeutics Contact Details

People in AeroLeads
2
With contact data
1
Email contacts
1
50.0% coverage
Phone contacts
1
50.0% coverage

Arcadia Therapeutics Org Chart

Sample employees and titles
Name Title Contact
John Johnson Web and Graphic Designer
View
Al Katawazi AI Technology Executive
Email Phone

Arcadia Therapeutics Tech Stack

Data / AI 1 profile
Product / design 1 profile

Compare Similar Companies to Arcadia Therapeutics